InvestorsHub Logo
Followers 2
Posts 44
Boards Moderated 0
Alias Born 08/17/2020

Re: Jack Torrance post# 127506

Sunday, 09/19/2021 5:38:10 PM

Sunday, September 19, 2021 5:38:10 PM

Post# of 200269
it was my email with lonza. here it is again — first is my email, then lonza’s IR reply:

I hope this email finds you well. I’m a shareholder with a few questions.

1. Are there any further details available regarding the future “additional Moderna products” that are a part of the collaboration agreement between Lonza and Moderna from May of last year that the company can disclose?

2. A press release was published in July outlining a work arrangement between Lonza and Enzolytics which was subsequently withdrawn due to inaccuracies. Is Lonza currently engaged in a service agreement with Enzolytics? If so, does the company intend to publish a PR detailing the agreement?

3. Is the cGMP facility in Guangzhou still on track to begin development of Pinteon’s Phase 1 clinical supply of PNT001 starting Q4 of this year?

Thanks for your time.

————

Good Afternoon,

Thank you for your mail and questions.

1. The strategic collaboration with Moderna is a 10 years contract.

2. Lonza and Enzolytics are not pursuing their collaboration at this time. We wish Enzolytics every success with its ventures going forward.

3. The new Lonza Biologics facility in Guangzhou, China is operational since the second quarter 2021.

Kind regards,